Wholesalers, GSK face off over profit margin of Augmentin

Things are going from bad to worse for domestic drug wholesalers these days as many pharmaceutical firms have further tightened their wallets amid concerns over falling revenue triggered by the government mandate drug price cuts in April.

Controversy is escalating between drug wholesalers and GlaxoSmithKline (GSK) over GSK’s desire to slash the profit margin of its antibiotic product Augment...